Definitive Healthcare Corp. - Class A Common Stock (DH)
5.3000
-0.0500 (-0.93%)
Definitive Healthcare Corp is a leading provider of healthcare data and analytics, specializing in delivering comprehensive insights to help organizations make informed decisions in the healthcare sector
The company offers a robust platform that aggregates data from various sources, including hospitals, physician practices, and other healthcare entities, facilitating a better understanding of market dynamics and patient care trends. By leveraging its extensive database, Definitive Healthcare supports clients in areas such as market analysis, strategic planning, and sales intelligence, ultimately enhancing efficiency and improving outcomes across the healthcare landscape.
FRAMINGHAM, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of Built In’s 100 Best Places to Work in Boston, MA for 2025. The annual awards program includes companies of all sizes, from startups to large enterprises, and honors both remote-first employers as well as companies in large tech markets across the U.S.
FRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the 27th Annual Needham Growth Conference.
FRAMINGHAM, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2024, on Thursday, November 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.
Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities
Law Offices of Howard G. Smith announces an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQDH) investors concerning the Company’s possible violations of federal securities laws.
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQDH) investors concerning the Company’s possible violations of the federal securities laws.
FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference.
The Law Offices of Frank R. Cruz announces an investigation of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQDH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights
FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Monday, August 5, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.
FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare’s Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare’s new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop’s commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
